Inhibrx Biosciences (INBX) Enterprise Value (2023 - 2025)
Inhibrx Biosciences (INBX) reported Enterprise Value of -$124.2 million for Q4 2025, up 18.6% year-over-year from -$104.7 million in Q4 2024, and up 18.86% quarter-over-quarter from -$153.1 million in Q3 2025.
Inhibrx Biosciences (INBX) Enterprise Value (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Enterprise Value data on file, last reported at -$124.2 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$124.2 million, up 18.6% year-over-year; the trailing twelve-month figure through Dec 2025 was -$124.2 million (up 18.6% YoY), and the FY2025 annual result was -$124.2 million, up 18.6% from the prior year.
- Enterprise Value climbed to -$124.2 million in Q4 2025 per INBX's latest filing, from -$153.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$124.2 million in Q4 2025 and troughed at -$277.9 million in Q4 2023.
- A 3-year average of -$191.8 million and a median of -$191.4 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value soared 45.09% in 2024, then rose 17.78% in 2025.
- A 3-year view of Enterprise Value shows it stood at -$277.9 million in 2023, then soared by 45.09% to -$152.6 million in 2024, then advanced by 18.6% to -$124.2 million in 2025.
- Business Quant data shows INBX's Enterprise Value at -$124.2 million in Q4 2025, -$153.1 million in Q3 2025, and -$186.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | -124.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -124.22 Mn |
| Sep 30, 2025 | -153.10 Mn |
| Jun 30, 2025 | -186.57 Mn |
| Mar 31, 2025 | -216.52 Mn |
| Dec 31, 2024 | -152.60 Mn |
| Sep 30, 2024 | -196.33 Mn |
| Jun 30, 2024 | -226.90 Mn |
| Dec 31, 2023 | -277.92 Mn |